1832 Asset Management Reduces Stake in UnitedHealth Group by 87.6%

Investment firm 1832 Asset Management L.P. has significantly reduced its holdings in UnitedHealth Group Incorporated (NYSE: UNH), decreasing its position by 87.6% during the second quarter of 2023. According to a recent filing with the Securities and Exchange Commission (SEC), the firm now holds 152,807 shares of the healthcare giant after selling 1,075,471 shares in the quarter, bringing the total value of its remaining stake to approximately $47.67 million.

This major divestment follows a trend among large investors making adjustments to their positions in UnitedHealth Group. Notably, LFA Lugano Financial Advisors SA acquired a new stake valued at around $25,000, while Bayforest Capital Ltd increased its stake by an impressive 685.7% during the first quarter, now holding 55 shares worth $29,000. Other firms, including Islay Capital Management LLC and Clal Insurance Enterprises Holdings Ltd, have also recently made moves, reflecting growing interest in the company’s stock.

Analyst Insights and Stock Performance

Analysts have been active in updating their ratings on UnitedHealth Group, with Wells Fargo & Company raising its price target from $267.00 to $400.00 and assigning an “overweight” rating. Deutsche Bank Aktiengesellschaft shifted its recommendation from “buy” to “hold,” setting a target price of $333.00. Meanwhile, Cantor Fitzgerald reaffirmed an “overweight” rating with a target of $440.00, and JPMorgan Chase & Co. raised its target from $310.00 to $425.00.

MarketBeat data indicates that UnitedHealth Group has garnered a consensus rating of “Moderate Buy,” with a consensus target price of $397.12. The company’s stock opened at $340.13 on October 28, 2023, and has shown a 4.8% increase.

The company’s recent quarterly earnings report revealed a $2.92 earnings per share (EPS), surpassing analysts’ expectations of $2.87. UnitedHealth Group reported revenue of $113.16 billion for the quarter, slightly below the projected $113.19 billion, but still reflecting a 12.2% year-over-year increase. The firm’s net margin stands at 4.04%, showcasing solid financial health.

Dividend Announcement and Business Overview

In addition to its financial performance, UnitedHealth Group announced a quarterly dividend of $2.21 per share, scheduled for payment on December 16, 2023. Shareholders on record by December 8, 2023, will be eligible to receive this dividend. This translates into an annualized dividend of $8.84, yielding approximately 2.6%.

UnitedHealth Group operates as a diversified healthcare company in the United States through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The company offers a wide range of health benefit plans and services catering to various sectors, including individual, employer, and public health programs.

As institutional investors and hedge funds collectively own 87.86% of UnitedHealth Group’s stock, the company remains a significant player in the healthcare sector, attracting ongoing attention from analysts and investors alike.